Franklin Resources’s Aura Biosciences AURA Stock Holding History

Franklin Resources’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.9M	Sell	2,072,726 -125,697	-6%	-$721K	﹤0.01%	1117
2025 Q4	$12M	Sell	2,198,423 -492	-0%	-$2.92K	﹤0.01%	1109
2025 Q3	$13.6M	Sell	2,198,915 -141,895	-6%	-$928K	﹤0.01%	1074
2025 Q2	$14.7M	Buy	2,340,810 +130,221	+6%	+$762K	﹤0.01%	1016
2025 Q1	$13M	Buy	2,210,589 +487,526	+28%	+$3.69M	﹤0.01%	1023
2024 Q4	$14.2M	Buy	1,723,063 +54,103	+3%	+$509K	﹤0.01%	1006
2024 Q3	$15.6M	Buy	1,668,960 +215,597	+15%	+$1.85M	﹤0.01%	970
2024 Q2	$11M	Hold	1,453,363	–	–	﹤0.01%	1039
2024 Q1	$11.4M	Buy	1,453,363 +853,245	+142%	+$7.07M	﹤0.01%	1032
2023 Q4	$5.32M	Buy	+600,118	New	+$5.08M	﹤0.01%	1100

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources's AURA Position: Q1 2026 in Review

Franklin Resources reduced its Aura Biosciences (AURA) stake by 5.7% in Q1 2026, selling an estimated $721K and leaving 2,072,726 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Franklin Resources first reported a position in AURA in Q4 2023 and has held it in 10 quarters since. The position peaked at $15.6M in Q3 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

Franklin Resources held 2,072,726 shares of Aura Biosciences worth $13.9M as of Q1 2026.
Franklin Resources sold 125,697 Aura Biosciences shares in Q1 2026, an estimated $721K.
Aura Biosciences made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1117 holding.
Franklin Resources first reported a position in Aura Biosciences in Q4 2023 and has held it in 10 quarters since.
Franklin Resources's Aura Biosciences position peaked at $15.6M in Q3 2024.
126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.